Biostax Corp (BTAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 0 | 2 | 30 | 5 |
| TOTAL | $N/A | $0 | $2 | $30 | $5 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 0 | 722 |
| Other Non-Current Assets | 6 | 6 | 6 | 6 | 6 |
| TOTAL | $6 | $6 | $6 | $6 | $728 |
| Total Assets | $6 | $6 | $8 | $35 | $732 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,589 | 1,574 | 1,522 | 1,509 | 1,634 |
| Accrued Expenses | 849 | 972 | 937 | 761 | 594 |
| Other current liabilities | 1,730 | 1,592 | 1,274 | 1,163 | 865 |
| TOTAL | $5,329 | $5,308 | $4,882 | $4,563 | $4,212 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,329 | $5,308 | $4,882 | $4,563 | $4,212 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,714 | 83,739 | 83,711 | 83,739 | 83,658 |
| Common Shares | 8 | 8 | 8 | 8 | 8 |
| Retained earnings | -386,148 | -386,112 | -385,684 | -385,331 | -384,278 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 10 |
| TOTAL | $-5,324 | $-5,303 | $-4,875 | $-4,528 | $-3,480 |
| Total Liabilities And Equity | $6 | $6 | $8 | $35 | $732 |